Combination of LC-MS- and GC-MS-based metabolomics to study the effect of ozonated autohemotherapy on human blood

Journal of Proteome Research

Volumn 11, Issue 12, 2012, Pages 6231-6241

  Ciborowski, Michal ^a,c   Lipska, Alina ^b   Godzien, Joanna ^c,d   Ferrarini, Alessia ^c   Korsak, Jolanta ^e   Radziwon, Piotr ^a,b   Tomasiak, Marian ^a   Barbas, Coral ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Regional Centre for Transfusion Medicine   (Poland)

^c UNIVERSIDAD SAN PABLO CEU   (Spain)

^d JOHN PAUL II CATHOLIC UNIVERSITY OF LUBLIN   (Poland)

^e MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

biomarkers; blood ozonation; fingerprinting; metabonomics

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; LACTIC ACID; LIPID; LYSOPHOSPHOLIPID; OZONE; PLASTIC; PLASTICIZER; POLYVINYLCHLORIDE; PYRUVIC ACID;

ANALYTIC METHOD; ARTICLE; BIOLEACHING; BLOOD DONOR; BLOOD SAMPLING; BLOOD STORAGE; BLOOD TRANSFUSION; CHEMICAL INTERACTION; CONTROLLED STUDY; GLYCOLYSIS; HUMAN; LIPID OXIDATION; LIPID OXIDATION PRODUCT; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; OXIDATIVE STRESS; OZONATED AUTOHEMOTHERAPY; OZONATION; PLASMA; PLASTIC BOTTLE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; BLOOD CELL COUNT; CHROMATOGRAPHY, LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEMOLYSIS; HUMANS; LACTIC ACID; LYSOPHOSPHOLIPIDS; MALE; METABOLOME; METABOLOMICS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OZONE; PLASTICS; POLYVINYL CHLORIDE; PYRUVIC ACID; YOUNG ADULT;

EID: 84870947005     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3008946     Document Type: Article

References (42)

1. Bocci, V.; Borrelli, E.; Travagli, V.; Zanardi, I. The ozone paradox: ozone is a strong oxidant as well as a medical drug Med. Res. Rev. 2009, 29 (4) 646-82
2. Sagai, M.; Bocci, V. Mechanisms of action involved in ozone therapy: Is healing induced via a mild oxidative stress? Med. Gas Res. 2011, 1, 29
3. Ueno, I.; Hoshino, M.; Miura, T.; Shinriki, N. Ozone exposure generates free radicals in the blood samples in vitro. Detection by the ESR spin-trapping technique Free Radic. Res. 1998, 29 (2) 127-35
4. Hernández, F. A. To what extent does ozone therapy need a real biochemical control system? Assessment and importance of oxidative stress Arch. Med. Res. 2007, 38 (5) 571-8
5. Bocci, V. A.; Zanardi, I.; Travagli, V. Ozone acting on human blood yields a hormetic dose-response relationship J. Transl. Med. 2011, 9, 66
6. Travagli, V.; Zanardi, I.; Bernini, P.; Nepi, S.; Tenori, L.; Bocci, V. Effects of ozone blood treatment on the metabolite profile of human blood Int. J. Toxicol. 2010, 29 (2) 165-74
7. Hernández, F.; Menéndez, S.; Wong, R. Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy Free Radic. Biol. Med. 1995, 19 (1) 115-9
8. Travagli, V.; Zanardi, I.; Bocci, V. A realistic evaluation of the action of ozone on whole human blood Int. J. Biol. Macromol. 2006, 39 (4-5) 317-20
9. Bocci, V.; Aldinucci, C. Biochemical modifications induced in human blood by oxygenation-ozonation J. Biochem. Mol. Toxicol. 2006, 20 (3) 133-8
10. Pryor, W. A.; Squadrito, G. L.; Friedman, M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products Free Radic. Biol. Med. 1995, 19 (6) 935-41
11. Travagli, V.; Zanardi, I.; Silvietti, A.; Bocci, V. A physicochemical investigation on the effects of ozone on blood Int. J. Biol. Macromol. 2007, 41 (5) 504-11
12. Shinriki, N.; Suzuki, T.; Takama, K.; Fukunaga, K.; Ohgiya, S.; Kubota, K.; Miura, T. Susceptibilities of plasma antioxidants and erythrocyte constituents to low levels of ozone Haematologia (Budap) 1998, 29 (3) 229-39
13. Zimran, A.; Wasser, G.; Forman, L.; Gelbart, T.; Beutler, E. Effect of ozone on red blood cell enzymes and intermediates Acta Haematol. 2000, 102 (3) 148-51
14. Nicholson, J.; Lindon, J.; Holmes, E. Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 1999, 29 (11) 1181-9
15. Lanza, I. R.; Zhang, S.; Ward, L. E.; Karakelides, H.; Raftery, D.; Nair, K. S. Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes PLoS One 2010, 5 (5) e10538
16. Want, E. J.; Cravatt, B. F.; Siuzdak, G. The expanding role of mass spectrometry in metabolite profiling and characterization Chembiochem 2005, 6 (11) 1941-51
17. Ide, T.; Tsutsui, H.; Ohashi, N.; Hayashidani, S.; Suematsu, N.; Tsuchihashi, M.; Tamai, H.; Takeshita, A. Greater oxidative stress in healthy young men compared with premenopausal women Arterioscler. Thromb. Vasc. Biol. 2002, 22 (3) 438-42
18. Ciborowski, M.; Teul, J.; Martin-Ventura, J. L.; Egido, J.; Barbas, C. Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprint PLoS ONE 2012, 7 (2) e31982
19. Whiley, L.; Godzien, J.; Ruperez, F. J.; Legido-Quigley, C.; Barbas, C. In-vial dual extraction for direct LC-MS analysis of plasma for comprehensive and highly reproducible metabolic fingerprinting Anal. Chem. 2012, 84 (14) 5992-5999
20. Milne, S.; Ivanova, P.; Forrester, J.; Alex Brown, H. Lipidomics: an analysis of cellular lipids by ESI-MS Methods 2006, 39 (2) 92-103
21. Garcia, A.; Barbas, C. Gas chromatography-mass spectrometry (GC-MS)-based metabolomics Methods Mol. Biol. 2011, 708, 191-204
22. Gika, H.; Macpherson, E.; Theodoridis, G.; Wilson, I. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2008, 871 (2) 299-305
23. Barañano, D. E.; Rao, M.; Ferris, C. D.; Snyder, S. H. Biliverdin reductase: a major physiologic cytoprotectant Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (25) 16093-8
24. Bulmer, A. C.; Ried, K.; Blanchfield, J. T.; Wagner, K. H. The anti-mutagenic properties of bile pigments Mutat. Res.: Rev. Mutat. Res. 2008, 658 (1-2) 28-41
25. Florczyk, U. M.; Jozkowicz, A.; Dulak, J. Biliverdin reductase: New features of an old enzyme and its potential therapeutic significance Pharmacol. Rep. 2008, 60 (1) 38-48
26. Sedlak, T. W.; Snyder, S. H. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle Pediatrics 2004, 113 (6) 1776-82
27. Ballatori, N.; Krance, S.; Notenboom, S.; Shi, S.; Tieu, K.; Hammond, C. Glutathione dysregulation and the etiology and progression of human diseases Biol. Chem. 2009, 390 (3) 191-214
28. du Plessis, L. H.; van der Westhuizen, F. H.; Kotze, H. F. The protective effect of plasma antioxidants during ozone autohemotherapy Afr. J. Biotechnol. 2008, 7 (14) 2472-7
29. Sardar, S.; Chakraborty, A.; Chatterjee, M. Comparative effectiveness of vitamin D3 and dietary vitamin E on peroxidation of lipids and enzymes of the hepatic antioxidant system in Sprague - Dawley rats Int. J. Vitam. Nutr. Res. 1996, 66 (1) 39-45
30. Wiseman, H. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action FEBS Lett. 1993, 326 (1-3) 285-8
31. Kadhum, A. A. H.; Wasmi, B. A.; Mohamad, A.; Al-Amiery, A. A.; Takriff, M. S. Preparation, characterization, and theoretical studies of azelaic acid derived from oleic acid by use of a novel ozonolysis method Res. Chem. Intermed. 2012, 38 (2) 659-68
32. Fitton, A.; Goa, K. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders Drugs 1991, 41 (5) 780-98
33. Breathnach, A. S. Azelaic acid: potential as a general antitumoural agent Med. Hypotheses 1999, 52 (3) 221-6
34. Litvinov, D.; Selvarajan, K.; Garelnabi, M.; Brophy, L.; Parthasarathy, S. Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice Atherosclerosis 2010, 209 (2) 449-54
35. Kühn, H. Biosynthesis, metabolization and biological importance of the primary 15-lipoxygenase metabolites 15-hydro(pero)XY-5Z,8Z,11Z,13E- eicosatetraenoic acid and 13-hydro(pero)XY-9Z,11E-octadecadienoic acid Prog. Lipid Res. 1996, 35 (3) 203-26
36. Kafoury, R.; Pryor, W.; Squadrito, G.; Salgo, M.; Zou, X.; Friedman, M. Lipid ozonation products activate phospholipases A2, C, and D Toxicol. Appl. Pharmacol. 1998, 150 (2) 338-49
37. Bocci, V. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br. J. Biomed. Sci. 1999, 56 (4) 270-9
38. Garcia, M. C.; Fernandez-Gallardo, S.; Gijon, M. A.; Garcia, C.; Nieto, M. L.; Sanchez Crespo, M. Biosynthesis of platelet-activating factor (PAF) in human polymorphonuclear leucocytes. The role of lyso-PAF disposal and free arachidonic acid Biochem. J. 1990, 268 (1) 91-8
39. Kotiaho, T.; Eberlin, M. N.; Vainiotalo, P.; Kostiainen, R. Electrospray mass and tandem mass spectrometry identification of ozone oxidation products of amino acids and small peptides J. Am. Soc. Mass Spectrom. 2000, 11 (6) 526-35
40. Jones, C. A.; Gordeyev, S. A.; Shilton, S. J. Poly(vinyl chloride) (PVC) hollow fibre membranes for gas separation Polymer 2011, 52 (4) 901-3
41. Chawla, A.; Hinberg, I. Leaching of plasticizers from and surface characterization of PVC blood platelet bags Biomater., Artif. Cells, Immobilization Biotechnol. 1991, 19 (4) 761-83
42. Rock, G.; Secours, V. E.; Franklin, C. A.; Chu, I.; Villeneuve, D. C. The accumulation of mono-2-ethylhexylphthalate (MEHP) during storage of whole blood and plasma Transfusion 1978, 18 (5) 553-8